Privia Health Group, Inc.
Privia Health is a technology-driven physician-enablement company that works with physician practices, health plans and health systems. It organizes physicians and other clinicians into regional Medical Groups, pairing provider autonomy with shared management, technology and population health services. Its Privia Platform supports clinical and practice operations, data analytics, revenue cycle management, payer contracting and value-based care. The Privia Technology Solution connects patient access, care delivery and follow-up workflows, including virtual visits. Privia Care Partners offers population health, reporting, analytics and management services to practices seeking value-based care solutions. Privia earns money from fee-for-service patient care and administrative services, per-member-per-month care management fees, value-based care payments such as capitation and shared savings, and other services. These include concierge services, virtual visits, clinical trials, behavioral health management and direct primary care partnerships with employers. As of December 31, 2025, Privia operates in 24 states and the District of Columbia, with over 1,300 practice locations. Its headquarters are in Arlington, Virginia.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $PRVA in the last 30 days.
See all $PRVA insider activity →Piper Sandler kept Privia Health Gr's rating at Overweight and increased its price target to $38 from $36, suggesting a 58.7% upside from the Nov 5 close of $23.94, according to the firm.
Privia Health Group, Inc. (PRVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results – YTD’26 Net Income of $25.6M, +85.9% from YTD’25 – YTD’26 Adjusted EBITDA of $114.7M, +21.9% from YTD’25 – Full-Year 2026 Guidance Raised to Above High End for All Key Financial Metrics – Expan
Privia Health Group (PRVA) reported Q3 2026 revenue of $657M, up 13.2% YoY, and net income of $13.5M, up 96.6%. YTD net income rose 85.9% to $25.6M. The company acquired American Choice Healthcare, adding 36K Medicare lives, and raised full-year guidance. It will exit Montana in 2027.
Over the past 7 days, AlphAI's AI scored 12 news stories mentioning PRVA (Privia Health Group, Inc.). Coverage has skewed bullish: 8 bullish, 3 neutral, and 1 bearish.
Recent PRVA coverage spans earnings, financial news and corporate actions.
Piper Sandler kept Privia Health Gr's rating at Overweight and increased its price target to $38 from $36, suggesting a 58.7% upside from the Nov 5 close of $23.94, according to the firm.
Raised guidance suggests stronger future earnings and cash flow.
Guidance lift and acquisition suggest stronger revenue growth, likely supporting the stock.
The upcoming earnings release may drive short-term volatility as investors price in guidance and results.
Board and compliance-committee appointment is a governance signal but not a direct financial catalyst.
AlphAI scores every news story that mentions PRVA with an AI model for sentiment and relevance, and aggregates insider trades from Privia Health Group, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Piper Sandler kept Privia Health Gr's rating at Overweight and increased its price target to $38 from $36, suggesting a 58.7% upside from the Nov 5 close of $23.94, according to the firm.
Privia Health Group, Inc. (PRVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results – YTD’26 Net Income of $25.6M, +85.9% from YTD’25 – YTD’26 Adjusted EBITDA of $114.7M, +21.9% from YTD’25 – Full-Year 2026 Guidance Raised to Above High End for All Key Financial Metrics – Expan
Privia Health Group (PRVA) reported Q3 2026 revenue of $657M, up 13.2% YoY, and net income of $13.5M, up 96.6%. YTD net income rose 85.9% to $25.6M. The company acquired American Choice Healthcare, adding 36K Medicare lives, and raised full-year guidance. It will exit Montana in 2027.
Privia Health (Nasdaq: PRVA) will release Q3 2026 financial results on Nov. 5, 2026, before market open, followed by a conference call at 8:00 am ET. The company operates in 25 states, optimizing 1,300+ physician practices and serving 6.1+ million patients.
Privia Health Group (NASDAQ:PRVA) said Dr. Opella Ernest will join its board of directors effective Sept. 1, 2026, and will serve on the Compliance Committee, according to the company’s press release. Ernest is President of HCSC Markets and previously held senior roles at HCSC. Privia operates networks in 25 states and DC, serving 6.1 million patients.
Privia Health Group, Inc. (PRVA) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors Dr. Ernest brings significant value-based care and clinical expertise ARLINGTON, VA – August 18, 2026 – Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella E
Privia Health Group (Nasdaq: PRVA) appointed Opella Ernest, M.D. to its board effective Sept. 1, 2026, and named her to the Compliance Committee. Privia said she has 20+ years of healthcare executive experience, including President of HCSC Markets at Health Care Service Corporation. The company did not provide financial figures.
Privia Health (PRVA) reported Q2 results and raised 2026 guidance on an Aug. 6 earnings call, citing growth in implemented providers, attributed lives, practice collections, and adjusted EBITDA. Management expects free cash flow conversion of 70% to 80% of adjusted EBITDA, citing potential CMS Medicare Shared Savings Program timing effects.
Privia Health (PRVA) reported Q2 revenue of $632.6M, up 21.4% year over year and above analysts’ $597.2M estimate, but adjusted EPS was $0.19 versus $0.24 expected. Management cited provider signings and growth in value-based attributed lives. Analysts asked about CMS shared savings timing, margin outlook, practice collections, AI use, and acquisition integration.
Privia Health Group (PRVA) shares rose 2.1% to $22.45 after its Q2 results. According to the company, Q2 revenue was $632.6m and adjusted EBITDA $37.4m. Management lifted full-year 2026 guidance, citing improving margins, while also flagging cash conversion dependence on MSSP settlements and execution risk in new states.
